• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma Pulse 4/17/24: AI has a Measurement Problem, How Advancements in Technology Are Transforming the Field & more


The latest news for pharma industry insiders.

Utilizing a Large Language Model to Answer Questions From Oncology Patients

Cross-sectional study observed responses to cancer care questions generated by artificial intelligence.

How Advancements in Technology Are Transforming the Field

AI offers many benefits in health professions by efficiently handling time-consuming tasks crucial for patient care.

AI Has a Measurement Problem

Which AI system writes the best computer code or generates the most realistic image? Right now, there’s no easy way to answer those questions.

Precision BioSciences Announces Return of Programs and Conclusion of Collaboration with Prevail Therapeutics

Precision BioSciences, Inc., an advanced gene editing company, announced the anticipated return of three programs from Prevail Therapeutics Inc., a wholly owned subsidiary of Eli Lilly and Company. Precision exercised its option to regain rights for the programs following Prevail Therapeutics’ decision to conclude the collaboration.

Cencora on X:

April is #EarthMonth. We’re investing in the earth’s future by working to reduce our emissions with renewable energy, alternate fuel vehicles, optimization programs, and more. Our science-based targets will help fight global warming. Learn how: https://ow.ly/Rbl450RfONt

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs